At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
Restylane SubQ +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Subject-blinded Study of Treatment Preference During Cheek Contouring Comparing Restylane® SubQ With and Without the Addition of Lidocaine Hydrochloride 0.3%
In Brief
A clinical study evaluating Restylane SubQ and Restylane SubQ Lidocaine for Facial Tissue Augmentation. Completed, enrolled 54 participants across 3 sites.
Detailed Summary
The objectives of this study are to evaluate the pain-relieving effect and safety of adding lidocaine hydrochloride to Restylane SubQ and to evaluate the esthetic improvement obtained. The study products will be administered in the cheek.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFacial Tissue Augmentation
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2011
First PostedSep 2011
Primary CompletionOct 2011
Study CompletionOct 2012
TodayJul 2026
First PostedSep 12, 2011
Enrollment StartSep 1, 2011
Primary CompletionOct 1, 2011
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.8 years ago
Interventions
Restylane SubQdevice
Treatment with up to 2 ml of the product
Restylane SubQ Lidocainedevice
Treatment with up to 2 ml of the product